Techne buys antibody-maker for $20M

Techne says its R&D Systems division has acquired Fortron Bio Science and BiosPacific for about $20 million. Fortron makes monoclonal and polyclonal antibodies and BiosPacific is its primary distribution arm.

- read this report from the AP for more

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.